Company Filing History:
Years Active: 2011
Title: Georg Brauers - Innovator in Radiopharmaceuticals
Introduction
Georg Brauers is a notable inventor based in Amersham, GB. He has made significant contributions to the field of radiopharmaceuticals, particularly with his innovative patent that addresses the stabilization of these complex compounds. His work has implications for medical imaging and treatment, showcasing the importance of stability in radiopharmaceutical compositions.
Latest Patents
Georg Brauers holds a patent for a "Stabiliser for radiopharmaceuticals." This patent describes a stabilized radiopharmaceutical composition, which includes a kit and a method for making the composition. The radiopharmaceutical is designed to be susceptible to either reductive degradation or radiolysis and includes a metal complex of a radionuclide with a ligand. The composition features a first stabilizer, which is an amino-substituted aromatic carboxylic acid or a salt, ester, or amide thereof. Additionally, a second stabilizer, which is a diphosphonic acid or salt thereof, is included. The stabilizers are present in effective amounts to ensure the stability of the radiopharmaceutical, which is not a metal complex of the diphosphonic acid. Georg Brauers has 1 patent to his name.
Career Highlights
Throughout his career, Georg Brauers has worked with prominent companies in the medical and pharmaceutical sectors. Notably, he has been associated with GE Healthcare Limited and Nihon Medi-Physics Company, Limited. His experience in these organizations has allowed him to contribute to advancements in medical technology and radiopharmaceuticals.
Collaborations
Georg Brauers has collaborated with esteemed professionals in his field, including Anthony Eamon Storey and Koichi Hanaoka. These collaborations have likely enriched his work and contributed to the development of innovative solutions in radiopharmaceuticals.
Conclusion
Georg Brauers is a distinguished inventor whose work in stabilizing radiopharmaceuticals has made a significant impact in the medical field. His patent and collaborations reflect his commitment to advancing technology in healthcare.